Related Experiment Videos

Antimicrobial susceptibility patterns of Haemophilus isolates from children in eleven developing nations. BOSTID

G A Weinberg1, E D Spitzer, P R Murray

  • 1Department of Pediatrics, Washington University School of Medicine, St. Louis, MO.

Insights

Most pediatric respiratory infections in developing countries show low resistance to common antibiotics. Penicillin G remains effective, supporting its use as a first-line treatment for childhood acute respiratory disease.

Area of Science:

  • Microbiology
  • Pediatrics
  • Infectious Diseases

Background:

  • Acute respiratory disease is a major cause of childhood mortality in developing countries.
  • Understanding antimicrobial resistance patterns in causative agents like Haemophilus species is crucial for effective treatment.
  • Global surveillance studies are essential to monitor antibiotic susceptibility trends.

Purpose of the Study:

  • To determine the antimicrobial susceptibilities of Haemophilus species isolated from children with acute respiratory disease in developing countries.
  • To assess the prevalence of resistance to key antibiotics, including ampicillin, chloramphenicol, and penicillin G.
  • To evaluate the suitability of current treatment guidelines for acute respiratory infections.

Main Methods:

  • Antimicrobial susceptibilities of 426 Haemophilus isolates were tested using the Haemophilus Test Medium.
  • Eleven different antibiotics were evaluated.
  • Minimum inhibitory concentrations (MICs) for penicillin and ampicillin were compared.

Main Results:

  • A low prevalence of antibiotic resistance was observed overall.
  • 6% of strains showed resistance to ampicillin, and 1.6% were resistant to chloramphenicol.
  • Resistance to both ampicillin and chloramphenicol was found only in isolates from Thailand. Penicillin G susceptibility was high, comparable to ampicillin.

Conclusions:

  • Haemophilus isolates demonstrate generally low resistance to ampicillin, chloramphenicol, and penicillin G.
  • Penicillin G is a viable and effective first-line agent for treating acute respiratory infections in children in developing nations.
  • Current treatment protocols utilizing penicillin G are supported by these findings.

Related Concept Videos